Genomic Imaging
for Precision Medicine

Better tests.
Better treatments.
Better outcomes.

3D Signatures is a personalized medicine company with a proprietary software platform designed to predict the course of certain diseases and to tailor treatment options for the individual patient.

Unlike other diagnostic companies, our platform goes beyond sequencing mutations in the DNA, to measure the stability of the entire genome.

TeloView™ incorporates multi-modal and structural parameters of a genome’s configuration.

We believe our analytics platform will tell doctors how to personalize treatment and best manage the disease for the individual patient.

Learn More >

Enabling Truly Personalized Medicine

Based on Dr. Sabine Mai’s groundbreaking research, 3D Signatures is the first and only company to understand and quantify normal versus disease state telomere arrangement, turning this into usable, predictable, reliable, and highly valuable information that can improve patient outcomes. This disruptive technology platform is fundamentally different from conventional diagnostic methods and could represent an entirely new class of biomarkers for diseases like cancer and Alzheimer’s.


Proprietary Platform Technology

$ 0 M+
in non-dilutive R&D funding
0 +
0 +
Clinical studies
0 +
Peer-reviewed papers